Guest guest Posted March 30, 2011 Report Share Posted March 30, 2011 Characterization of the Cross-Neutralizing Antibody Response Against Hepatitis C Virus in the Liver Transplantation Setting (pages 767¨C774) J. Dragun, S. P¨¦rez-del-Pulgar, G. Crespo, S. Ram¨ªrez, M. Coto-Llerena, L. Mensa, J. C. Garc¨ªa-Valdecasas, M. Navasa and X. Forns Article first published online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03440.x This study of liver allograft recipients with hepatitis C virus suggests that viral adaptation may account for early viral kinetics following liver transplantation. Characterization of HCV-Specific CD4+Th17 Immunity in Recurrent Hepatitis C¨CInduced Liver Allograft Fibrosis (pages 775¨C785) H. I. Basha, V. Subramanian, A. Seetharam, D. S. Nath, S. Ramachandran, C. D. , S. Shenoy, W. C. Chapman, J. S. Crippin and T. Mohanakumar Article first published online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03458.x This study demonstrates that recurrent hepatitis C virus infection following orthotopic liver transplantation leads to increased IL-6, IL-1¦Â and decreased IFN- which induces hepatitis C virus specific CD4+Th17 cells, which may play a role in allograft fibrosis and cirrhosis. Potential Transmission of Viral Hepatitis Through Use of Stored Blood Vessels as Conduits in Organ Transplantation¡ªPennsylvania, 2009 (pages 863¨C865) Article first published online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03522.x As detailed in this report, stored vessels from donors with hepatitis may be a potential source of donor-derived hepatitis when used in transplant recipients. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.